Cargando…

Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans Simultaneously by MALDI-MS

[Image: see text] Differences in ionization efficiency among neutral and sialylated glycans prevent direct quantitative comparison by their respective mass spectrometric signals. To overcome this challenge, we developed an integrated chemical strategy, Dual Reactions for Analytical Glycomics (DRAG),...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Hui, Warren, Peter G., Froehlich, John W., Lee, Richard S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082391/
https://www.ncbi.nlm.nih.gov/pubmed/24766348
http://dx.doi.org/10.1021/ac500298a
_version_ 1782324251001356288
author Zhou, Hui
Warren, Peter G.
Froehlich, John W.
Lee, Richard S.
author_facet Zhou, Hui
Warren, Peter G.
Froehlich, John W.
Lee, Richard S.
author_sort Zhou, Hui
collection PubMed
description [Image: see text] Differences in ionization efficiency among neutral and sialylated glycans prevent direct quantitative comparison by their respective mass spectrometric signals. To overcome this challenge, we developed an integrated chemical strategy, Dual Reactions for Analytical Glycomics (DRAG), to quantitatively compare neutral and sialylated glycans simultaneously by MALDI-MS. Initially, two glycan samples to be compared undergo reductive amination with 2-aminobenzoic acid and 2-(13)[C(6)]-aminobenzoic acid, respectively. The different isotope-incorporated glycans are then combined and subjected to the methylamidation of the sialic acid residues in one mixture, homogenizing the ionization responses for all neutral and sialylated glycans. By this approach, the expression change of relevant glycans between two samples is proportional to the ratios of doublet signals with a static 6 Da mass difference in MALDI-MS and the change in relative abundance of any glycan within samples can also be determined. The strategy was chemically validated using well-characterized N-glycans from bovine fetuin and IgG from human serum. By comparing the N-glycomes from a first morning (AM) versus an afternoon (PM) urine sample obtained from a single donor, we further demonstrated the ability of DRAG strategy to measure subtle quantitative differences in numerous urinary N-glycans.
format Online
Article
Text
id pubmed-4082391
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-40823912015-04-25 Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans Simultaneously by MALDI-MS Zhou, Hui Warren, Peter G. Froehlich, John W. Lee, Richard S. Anal Chem [Image: see text] Differences in ionization efficiency among neutral and sialylated glycans prevent direct quantitative comparison by their respective mass spectrometric signals. To overcome this challenge, we developed an integrated chemical strategy, Dual Reactions for Analytical Glycomics (DRAG), to quantitatively compare neutral and sialylated glycans simultaneously by MALDI-MS. Initially, two glycan samples to be compared undergo reductive amination with 2-aminobenzoic acid and 2-(13)[C(6)]-aminobenzoic acid, respectively. The different isotope-incorporated glycans are then combined and subjected to the methylamidation of the sialic acid residues in one mixture, homogenizing the ionization responses for all neutral and sialylated glycans. By this approach, the expression change of relevant glycans between two samples is proportional to the ratios of doublet signals with a static 6 Da mass difference in MALDI-MS and the change in relative abundance of any glycan within samples can also be determined. The strategy was chemically validated using well-characterized N-glycans from bovine fetuin and IgG from human serum. By comparing the N-glycomes from a first morning (AM) versus an afternoon (PM) urine sample obtained from a single donor, we further demonstrated the ability of DRAG strategy to measure subtle quantitative differences in numerous urinary N-glycans. American Chemical Society 2014-04-25 2014-07-01 /pmc/articles/PMC4082391/ /pubmed/24766348 http://dx.doi.org/10.1021/ac500298a Text en Copyright © 2014 American Chemical Society Terms of Use (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html)
spellingShingle Zhou, Hui
Warren, Peter G.
Froehlich, John W.
Lee, Richard S.
Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans Simultaneously by MALDI-MS
title Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans Simultaneously by MALDI-MS
title_full Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans Simultaneously by MALDI-MS
title_fullStr Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans Simultaneously by MALDI-MS
title_full_unstemmed Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans Simultaneously by MALDI-MS
title_short Dual Modifications Strategy to Quantify Neutral and Sialylated N-Glycans Simultaneously by MALDI-MS
title_sort dual modifications strategy to quantify neutral and sialylated n-glycans simultaneously by maldi-ms
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082391/
https://www.ncbi.nlm.nih.gov/pubmed/24766348
http://dx.doi.org/10.1021/ac500298a
work_keys_str_mv AT zhouhui dualmodificationsstrategytoquantifyneutralandsialylatednglycanssimultaneouslybymaldims
AT warrenpeterg dualmodificationsstrategytoquantifyneutralandsialylatednglycanssimultaneouslybymaldims
AT froehlichjohnw dualmodificationsstrategytoquantifyneutralandsialylatednglycanssimultaneouslybymaldims
AT leerichards dualmodificationsstrategytoquantifyneutralandsialylatednglycanssimultaneouslybymaldims